Anumana vs Etiometry Platform
Anumana's flagship algorithm flags reduced ejection fraction from a 10-second 12-lead ECG and posts the result in the EHR as a notification, so the buyer is a hospital's ECG workflow. Etiometry belongs in the ICU. Its platform pulls monitor, device and EHR data into one view, and the vendor lists four FDA-cleared risk indices for oxygen delivery, ventilation, lactate and acidosis. Three of the four are cleared only for patients up to 12 years old, which makes a pediatric cardiac ICU the natural buyer. openFDA shows 11 Etiometry clearances in total. The vendor says it supports SMART-on-FHIR integrations and signs BAAs, and states SOC 2, HIPAA and ISO 27001 compliance. Neither company publishes a price. A hospital with a cardiac ICU and an ECG workflow could license both without any overlap.
Decision support · Reviewed November 2, 2026

Anumana
by Anumana
ECG-AI software that flags low ejection fraction, pulmonary hypertension and cardiac amyloidosis from standard 12-lead ECGs.

Etiometry Platform
by Etiometry · founded 2010
ICU data platform that aggregates monitor and EHR data and runs four FDA-cleared physiologic risk indices.
When to pick each one
Anumana
- Flags reduced ejection fraction from a 10-second ECG
- Result arrives as an EHR notification
Etiometry Platform
- Four ICU risk indices the vendor calls FDA-cleared
- SOC 2, HIPAA, ISO 27001 and BAAs stated
Score
Each row shows points earned of points available under the published rubric.
Anumana
37of 100
Etiometry Platform
38of 100
| Dimension | Anumana | Etiometry Platform | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 12 / 12 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 10 / 10 | -10 |
| EHR integrations (count) | 0 / 5.6 | 0 / 5.6 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 0 / 4.8 | 0 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 14.7 / 21 | 0 / 21 | +14.7 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 6 / 6 | -6 |
Scroll horizontally to see every column.
Pricing
Anumana
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. The pricing page returns 404; the site offers a demo request only. |
Etiometry Platform
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Demo request only. |
Evidence
Anumana
FDA decisions
K253801 (opens in new tab)510(k)2026-04-07
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040)
K252360 (opens in new tab)510(k)2026-03-28
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020)
K250652 (opens in new tab)510(k)2025-07-28
ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010)
K232699 (opens in new tab)510(k)2023-09-28
Low Ejection Fraction AI-ECG Algorithm
Peer-reviewed
3 PubMed records name Anumana.
- A Pragmatic Trial Evaluating the Impact of the Anumana Clinical Decision Support Tool for Guideline-Directed Management of Heart Failure (ACT-HF): Clinical trial design and methods. (opens in new tab)
- Comment on "A pragmatic trial evaluating the impact of the anumana clinical decision support tool for guideline-directed management of heart failure (ACT-HF): Clinical trial design and methods". (opens in new tab)
- Identification and risk stratification of coronary disease by artificial intelligence-enabled ECG. (opens in new tab)
Etiometry Platform
FDA decisions
K254066 (opens in new tab)510(k)2026-04-03
Etiometry Platform
K241479 (opens in new tab)510(k)2025-02-12
Etiometry Platform (DAV 5.4 RAE 9.2)
K223578 (opens in new tab)510(k)2023-07-07
T3 Platform software
K213423 (opens in new tab)510(k)2023-01-06
T3 Platform software
K213230 (opens in new tab)510(k)2022-06-22
T3 Platform Software
Show 6 more
K202306 (opens in new tab)510(k)2020-11-25
T3 Platform software
K190273 (opens in new tab)510(k)2019-12-08
T3 Platform software
K163065 (opens in new tab)510(k)2017-05-26
T3 Software
K152258 (opens in new tab)510(k)2016-03-31
T3 Software
K151715 (opens in new tab)510(k)2015-10-29
T3 Software
K142732 (opens in new tab)510(k)2015-03-04
T3 Software
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Anumana | Etiometry Platform |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | 2010 |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.
